Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 46.50
Bid: 46.00
Ask: 47.00
Change: -0.25 (-0.53%)
Spread: 1.00 (2.174%)
Open: 45.75
High: 46.50
Low: 45.50
Prev. Close: 46.75
AVCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Omega Wins First Order For Antibody Test

Tue, 09th Jun 2020 11:14

(Alliance News) - The following is a round-up of updates by London-listed companies on the impact of the Covid-19 pandemic, issued on Tuesday and not separately reported by Alliance News:

----------

Avacta Group PLC - Wetherby-based Affimer biotherapeutics developer - Bead-assisted mass spectrometry diagnostics test for Covid-19 infection being developed with partner Adeptrix has reached prototype stage, and can detect the coronavirus spike protein in model sample in the range appropriate for a clinical diagnostic test. Next development step is evaluate and optimise assay before moving to manufacturing and clinical validation.

----------

Omega Diagnostics PLC - Alva-based medical diagnostics - Expects Ebitda for year ended March between GBP850,000 to GBP900,000, ahead of market expectations and up from GBP199,668. Signs long-term supply agreement with Mologic Ltd, for the supply of raw materials for Omega to manufacture its CE-Marked ELISA antibody test. Also signs material transfer agreement with Mologic. Announces first order for test to Senegal worth GBP100,000.

----------

Braveheart Investment Group PLC - Barnsley-based investment holding firm - Paraytec announces that the required affinity macromolecule an aptamer that bonds to the SPIKE glycoprotein on the surface of the Covid-19 virus has been synthesised and supplied to Paraytec from the University of Sheffield. Paraytec expects to complete the production of SPIKE protein in cell factories, and modification of test surface with aptamer in one month.

----------

Ilika PLC - Romsey-based solid-state battery firm - Trading for year ended April 30 in line with expectations. Revenue expected to be GBP2.8 million, up from GBP2.6 million, and narrowed Lbitda of GBP2.1 million from GBP2.2 million. Romsey headquarters remains open throughout lockdown period, while data analytics and business discussions have continued remotely. Expects Stereax pilot line at University of Southampton to reopen shortly.

----------

Sosandar PLC - Cheshire-based women's clothing retail - Reports strong growth in first two months of financial year ending March 31, 2021 despite challenges. Order growth for two months to May 31 up 44% year-on-year, revenue grows by 62%. Increased traffic up 98%, but lower levels of conversion. Marketing expenses reduced, 60% of workforce furloughed, board remuneration reduced. For recently ended year, expects revenue to be at least GBP9 million, up from GBP4.4 million.

----------

SigmaRoc PLC - London-based construction materials - For five months ended May, reports revenue of GBP42 million. In April and May, restriction in Channel Islands lifted allowing Ronez operations to resume more normal trading. In UK, PPG and South Wales platforms scaled up towards full production at end of April and into May. Belgium operations remained active, despite lower activity level.

----------

S&U PLC - Birmingham-based motor finance & property bridging lender - In Advantage Finance, sales for financial year-to-date down to 15% of normal levels due to plummeting car usage, closure of car dealers and ceasing of deliveries, But transactions have now recovered to around 40% of normal. In Aspen Bridging, transaction numbers under a quarter of those budgeted in the year. Improvement seen in both segments.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
8 Mar 2021 11:06

Avacta confirms efficacy of test on variant Covid-19 strains

(Sharecast News) - Cancer therapies and diagnostics company Avacta announced on Monday that its 'AffiDX' SARS-CoV-2 rapid antigen lateral flow test detected the dominant new variants of coronavirus, known as the B117 or 'Kent', variant, and the D614G variant, as well as the original strain.

Read more
24 Feb 2021 11:45

TRADING UPDATES: Avacta Plans Covid Test Launch Near First Quarter End

TRADING UPDATES: Avacta Plans Covid Test Launch Near First Quarter End

Read more
24 Feb 2021 10:25

AIM WINNERS & LOSERS: Mkango Hails Pilot Plant Processing Milestone

AIM WINNERS & LOSERS: Mkango Hails Pilot Plant Processing Milestone

Read more
22 Feb 2021 11:01

AIM WINNERS & LOSERS: Clear Leisure Surges Amid Placing, Bitcoin Plans

AIM WINNERS & LOSERS: Clear Leisure Surges Amid Placing, Bitcoin Plans

Read more
22 Feb 2021 09:28

Avacta Focusing On Full Clinical Validation Of Rapid Covid-19 Test

Avacta Focusing On Full Clinical Validation Of Rapid Covid-19 Test

Read more
22 Feb 2021 08:54

Avacta clarifies reports on potential use of its Covid-19 test

(Sharecast News) - Avacta Group responded to some press speculation on take-up of its lateral flow SARS-CoV-2 rapid antigen test for Covid-19 by the UK government on Monday.

Read more
22 Feb 2021 08:47

LONDON MARKET OPEN: European Equities Slip Amid Inflation Fears

LONDON MARKET OPEN: European Equities Slip Amid Inflation Fears

Read more
18 Feb 2021 14:31

IN BRIEF: Avacta Gets Phase I Clinical Trial Approval For AVA6000

IN BRIEF: Avacta Gets Phase I Clinical Trial Approval For AVA6000

Read more
18 Feb 2021 08:49

Avacta gets approval for first-in-human study of AVA6000

(Sharecast News) - Biotherapeutics and reagents developer Avacta has received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) for a phase 1 study of its lead 'preCISION' pro-drug, AVA6000 pro-doxorubicin, it announced on Thursday.

Read more
16 Feb 2021 11:31

AIM WINNERS & LOSERS: Cornish Metals Jumps 40% On AIM Debut

AIM WINNERS & LOSERS: Cornish Metals Jumps 40% On AIM Debut

Read more
16 Feb 2021 09:48

Avacta Shares Surge On Positive Data For Covid-19 Antigen Test

Avacta Shares Surge On Positive Data For Covid-19 Antigen Test

Read more
16 Feb 2021 09:38

Avacta upbeat on initial data for Covid-19 rapid test study

(Sharecast News) - Biotherapeutics and reagents developer Avacta Group has received the first data for its SARS-CoV-2 rapid antigen test from ongoing clinical studies in Europe and the UK, it announced on Tuesday.

Read more
8 Feb 2021 11:25

Avacta enters commercial partnership with Mologic

(Sharecast News) - Biotherapeutics developer Avacta Group has entered into a commercial partnership with Mologic, it announced on Monday, to accelerate to market its 'AffiDX' SARS-CoV-2 lateral flow rapid antigen test.

Read more
8 Feb 2021 10:46

AIM WINNERS & LOSERS: Bahamas Petroleum Sinks As Pulls Plug On Well

AIM WINNERS & LOSERS: Bahamas Petroleum Sinks As Pulls Plug On Well

Read more
8 Feb 2021 09:37

Avacta Signs Agreement With Mologic For AffiDX Covid-19 Antigen Test

Avacta Signs Agreement With Mologic For AffiDX Covid-19 Antigen Test

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.